Overexpressing PTPN14 inhibits anoikis resistance, tumorigenicity, and metastasis in TNBC cells by dephosphorylating breast cancer antiestrogen resistance 3, affecting the PI3K/AKT and ERK pathways. Here, PTPN14 is linked to breast carcinoma.